The raw material medicine production base is located in the bio-pharmaceutical park of Zhumadian industrial cluster with an area of 800 mu and a total investment of 1.55 billion yuan. The first phase of the project covers an area of 400 mu with a total investment of 700 million yuan. The chemical raw materials of doxycycline, Cyromazine sulfadimethoxine sodium, florfenicol, tilmicosin, enrofloxacin, ciprofloxacin lactate, and other bio-fermentation drug tylosin, acetyl ethyl valeroyl tylosin and other products; currently a number of production lines have been completed and put into production, which is one of the most potential profit growth poles of Houyi Group.